Actively Recruiting
Laryngoscopy for Neonatal and Infant Airway Management with Supplemental Oxygen at Different Flow Rates (OPTIMISE-2): A Multi-center, Non-inferiority, Prospective Randomized Controlled Trial
Led by Thomas Riva · Updated on 2026-05-12
1192
Participants Needed
11
Research Sites
13 weeks
Total Duration
On this page
Sponsors
T
Thomas Riva
Lead Sponsor
U
University Hospital, Geneva
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to find the best oxygen flow rate during tracheal intubation using the C-MAC video laryngoscope with Miller or Macintosh blades in newborns and infants up to 52 weeks postconceptual age. The study focuses on whether low-flow supplemental oxygen differs significantly from high-flow oxygen during intubation in the operating room or intensive care unit. The goal is to see if both oxygen flow rates are similarly effective in managing the airway safely. Eligible children will be randomly assigned to receive either low-flow oxygen at 0.2 L/kg/min via nasal cannula or high-flow oxygen at 2 L/kg/min using the Optiflow device during intubation. All patients are pre-oxygenated before anesthesia induction and given muscle relaxants and sedatives according to protocol. Intubation is done orally or nasally with specified tube sizes based on the child's weight, using the C-MAC laryngoscope with blade sizes appropriate for their size. If intubation is difficult, specific protocols and devices will be used to secure the airway. Participants will be closely monitored with vital signs like oxygen saturation, heart rate, and blood pressure. Researchers will track success rates of first intubation attempts, number of attempts, time to intubate, oxygen levels, and any respiratory complications up to 24 hours post-intubation. The study includes careful assessments during and after intubation to evaluate airway management effectiveness and safety within 15 minutes of the procedure. Total participation covers the intubation procedure and immediate follow-up monitoring.
CONDITIONS
Brief Title
Laryngoscopy for Neonatal and Infant Airway Management wIth Supplemental Oxygen at Different Flow Rates (OPTIMISE-2)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pediatric patients requiring oral or nasal tracheal intubation for elective, semi-elective, or urgent surgical and non-surgical indications.
- Neonates and infants up to 52 weeks postconceptual age.
- Legal guardians must provide written informed consent before the intervention.
You will not qualify if you...
- Predicted difficult intubation based on physical exam or history requiring a technique other than direct laryngoscopy.
- Congenital heart disease requiring less than 100% oxygen.
- Cardiopulmonary collapse needing advanced life support.
- Intubation for emergency surgical and non-surgical indications.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single procedure day
Participants undergo tracheal intubation with supplemental oxygen administered at randomized low-flow or high-flow rates using specific nasal cannulas and the C-MAC video laryngoscope to manage the airway.
1 procedure visit (in-person)
Duration - Up to 24 hours
Participants are monitored for respiratory complications and other safety outcomes following the intubation procedure.
Approximately 1 follow-up visit (in-person)
Trial Site Locations
Total: 11 locations
1
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
2
Perth Children's Hospital
Perth, Western Australia, Australia, 6009
Actively Recruiting
3
Hospital Municipal Infantil Menino Jesus, Servicos Medicos de Anestesia
São Paulo, São Paulo, Brazil
Actively Recruiting
4
Dept. Anesthesia, The Hospital for Sick Children
Toronto, Ontario, Canada
Actively Recruiting
5
Dept. Anesthesia, Montreal Children's Hospital, McGill University Health Centre
Montreal, Canada
Actively Recruiting
6
Department of Cardiac Anesthesiology and Intensive Care Medicine, Charité Universitätsmedizin
Berlin, Germany
Actively Recruiting
7
IRCCS Istituto Giannina Gaslini
Genova, Italy, 16147
Actively Recruiting
8
Kantonsspital Aarau, KSA
Aarau, Canton of Aargau, Switzerland
Actively Recruiting
9
Luzerner Kantonsspital
Lucerne, Canton of Lucerne, Switzerland, 6004
Actively Recruiting
10
Inselspital
Bern, Switzerland, 3010
Actively Recruiting
11
CHUV Centre Hospitalier Universitaire Vaudois
Lausanne, Switzerland, 1011
Active, Not Recruiting
Research Team
A
Alexander Fuchs, MD
T
Thomas Riva, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here